NCT02291055View on ClinicalTrials.gov

A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 9, 2019

Study Completion Date

November 20, 2020

Conditions
Cervical CancerCancerHead and Neck Cancer
Interventions
DRUG

ADXS11-001

DRUG

MEDI4736

Trial Locations (17)

Unknown

Site, Los Angeles

Site, New Haven

Site, Jacksonville

Site, Miami

Site, Tampa

Site, Urbana

Site, Lexington

Site, Baltimore

Site, Detroit

Site, Omaha

Site, Brooklyn

Site, New York

Site, Canton

Site, Hilliard

Site, Oklahoma City

Site, Chattanooga

Site, Milwaukee

Sponsors

Lead Sponsor

Advaxis, Inc.

Collaborators (1)

MedImmune LLC
All Listed Sponsors
collaborator

MedImmune LLC

INDUSTRY

lead

Advaxis, Inc.

INDUSTRY